๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A new extracorporeal liver support system for chronic liver disease complicated by cholestasis and liver failure-results of a prospective controlled randomised trial

โœ Scribed by Stange, Jan; Mitzner, Steffen R.; Klammt, Sebastian; Schmidt, Reinhardt; Treichel, Ullrich; Loock, Jan; Gerken, Guido


Book ID
124119038
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
186 KB
Volume
120
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Efficacy and safety of high-dose pravast
โœ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 148 KB ๐Ÿ‘ 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place

An interim analysis of a phase II/III pr
An interim analysis of a phase II/III prospective randomized, multicenter, controlled trial of the hepatassistยฎ bioartificial liver support system for the treatment of fulminant hepatic failure: Anthony C Stevens, Circe Biomed, Lexington, MA; R Busuttil, S Han, A Baquerizo, UCLA, Los Angeles, CA; J Fair, R Shrestha, M Johnson, UNC Sch of Medicine, Chapel Hill, NC; J Bloomer, B McGuire, Univ of Alabama, Birmingham, AL; P Rosenthal, N Ascher, C Freise, UCSF, San Francisco, CA; F Watanabe, Cedars Sinai Medical Ctr, Los Angeles, CA; X Rogiers, J Schulte am Esch, Univ Krankenhauf Eppendorf, Hamburg Germany; S Nyberg, R H Wiesner, Mayo Clinic, Rochester, MN; C Broelsch, M Malago, Universitatsklinikum Essen, Essen Germany; A Kribben, J Lerut, Cliniques Universitaires St Luc, Brussels Brussels Belgium; P Laterre, Cliniques Universitaires St Luc, Brussels Belgium; M Salizzoni, B Lavezzo, San Giovanni Battista di Torino, Turin Italy; R Brown, J Emond, S Lobritto, New York Presbyterian Hosp, New York, NY; B de Hemptinne, F Colardyn, E Hoste, Universitair Zeikenhaus Ghent, Ghent Belgium; E Fagan, Rush Presbyterian, Chicago, IL; L McChesney, Univ of Toledo, Toledo, OH; M Muraca, Univ di Padova, Padova Italy; A Mas Ordeig, J Salmeron, Hosp Clinic Provincial de Barcelona, Barcelona Spain; J Rabkin, Oregon Health Sciences Univ, Portland, OR; D Pratt, New England Medical Ctr, Boston, MA; M de la Mata, J Montero, J Pozo, Hosp Reina Sofia, Cordova Spain; H Metselaar, Univ Hosp Rotterdam, Rotterdam, The Netherlands, Rotterdam Netherlands; G Everson, Univ of Colorado, Denver, CO; Z Pitkin, C Mullon, B Solomon, Circe Biomed, Lexington, MA; A Demetriou, Cedars Sinai Medical Ctr, Los Angeles, CA
๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 245 KB